Evaluation of Aficamten in Patients with Symptomatic Non-obstructive Hypertrophic Cardiomyopathy: REDWOOD HCM Cohort 4
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy
Withdrawal of Background Standard of Care Medical Therapy in Patients with Obstructive Hypertrophic Cardiomyopathy Treated with Aficamten in REDWOOD HCM OLE
Effects of Omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial
Efficacy and Safety of Aficamten in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy
Influence of Atrial Fibrillation on Efficacy and Safety of Omecamtiv Mecarbil in Heart Failure: the GALACTIC-HF Trial
Adverse Drug Effects Across Patients With Heart Failure: A Systematic Review
Developments in Exercise Capacity Assessment in Heart Failure Clinical Trials and the Rationale for the Design of METEORIC-HF
Managing the Economic Challenges in the Treatment of Heart Failure
Grip Strength is More Than a Number: The Relationship Between Grip Strength and Fine Motor and Arm Function in FORTITUDE-ALS